Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
To study the individual effects of glucagon and growth hormone on human carbohydrate and lipid metabolism, endogenous secretion of both hormones was simultaneously suppressed with somatostatin and physiologic circulating levels of one or the other hormone were reproduced by exogenous infusion. The interaction of these hormones with insulin was evaluated by performing these studies in juvenile-onset, insulin-deficient diabetic subjects both during infusion of insulin and after its withdrawal. Infusion of glucagon (1 ng/kg-min) during suppression of its endogenous secretion with somatostatin produced circulating hormone levels of approximately 200 pg/ml. When glucagon was infused along with insulin, plasma glucose levels rose from 94 +/- 8 to 126 +/- 12 mg/100 ml over 1 h (P less than 0.01); growth hormone, beta-hydroxy-butyrate, alanine, FFA, and glycerol levels did not change. When insulin was withdrawn, plasma glucose, beta-hydroxybutyrate, FFA, and glycerol all rose to higher levels (P less than 0.01) than those observed under similar conditions when somatostatin alone had been infused to suppress glucagon secretion. Thus, under appropriate conditions, physiologic levels of glucagon can stimulate lipolysis and cause hyperketonemia and hyperglycemia in man; insulin antagonizes the lipolytic and ketogenic effects of glucagon more effectively than the hyperglycemic effect. Infusion of growth hormone (1 mug/kg-h) during suppression of its endogenous secretion with somastostatin produced circulating hormone levels of approximately 6 ng/ml. When growth hormone was administered along with insulin, no effects were observed. After insulin was withdrawn, plasma beta-hydroxybutyrate, glycerol, and FFA all rose to higher levels (P less than 0.01) than those observed during infusion of somatostatin alone when growth hormone secretion was suppressed; no difference in plasma glucose, alanine, and glucagon levels was evident. Thus, under appropriate conditions, physiologic levels of growth hormone can augment lipolysis and ketonemia in man, but these actions are ordinarily not apparent in the presence of physiologic levels of insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glucagon has also effects on lipid metabolism stimulates lipolysis and hepatic fatty acid oxidation [197] but its effects should be always be considered relative to the insulin levels since insulin exerts opposite effects on lipid metabolism [198].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [198]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Felig, P. (1973) · Metabolism · doi:10.1016/0026-0495(73)90269-2 · Cited by 794
The essential role of glucagon in the pathogenesis of diabetes mellitus
Unger, R., & Orci, L. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92375-2 · Cited by 599
INHIBITION OF INSULIN SECRETION BY SOMATOSTATIN
Alberti, K. G. M. M., Juel Christensen, N., Engkjær Christensen, S., Prange Hansen, A., Iversen, J., Lundbæk, K., Seyer-Hansen, K., & Ørskov, H. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92873-0 · Cited by 457
EFFECT OF GROWTH HORMONE ON PLASMA FATTY ACIDS*
Raben, M. S., & Hollenberg, C. H. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103824 · Cited by 445
Gerich, J. E., Lorenzi, M., Bier, D. M., Schneider, V., Tsalikian, E., Karam, J. H., & Forsham, P. H. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505082921901 · Cited by 354
Self-citationGlucagon levels and metabolic effects in fasting man
Marliss, E. B., Aoki, T. T., Unger, R. H., Soeldner, J. S., & Cahill, G. F. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106445 · Cited by 339
Fain, J. N., Kovacev, V. P., & Scow, R. O. (1965) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)97175-9 · Cited by 270
Mortimer, C. H., Carr, D., Lind, T., Bloom, S. R., Mallinson, C. N., Schally, A. V., Tunbridge, W. M. G., Yeomans, L., Coy, D. H., Kastin, A., et al. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92903-1 · Cited by 268
Gerich, J. E., Lorenzi, M., Schneider, V., Karam, J. H., Rivier, J., Guillemin, R., & Forsham, P. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197409122911102 · Cited by 239
Self-citationGlucagon: Role in the Hyperglycemia of Diabetes Mellitus
Dobbs, R., Sakurai, H., Sasaki, H., Faloona, G., Valverde, I., Baetens, D., Orci, L., & Unger, R. (1975) · Science · doi:10.1126/science.1089999 · Cited by 229
Research works printed but not linked: 2
- [51]51. Lefebvre, P. 1972. Glucagon and lipid metabolism. In Glucagon: Molecular Physiology, Clinical and Therapeutic Implications. P. Lefebvre and R. H. Unger, editors. Pergamon Press, Inc., Elmsford, N. Y. 109–121.
- [57]57. Davidoff, F. 1968. The disturbances of carbohydrate metabolism in acromegaly—a perspective view, 19271967. Proc. Rudolf Virchow Med. Soc. City N. Y. 26 (Suppl.): 83-115.
Cited by
Management of Hyperglycemic Crises in Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., & Wall, B. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.131 · Cited by 710
Effect of Growth Hormone on Carbohydrate and Lipid Metabolism
DAVIDSON, M. B. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-115 · Cited by 573
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369
Self-citationThe Effect of Growth Hormone on Glucose Metabolism and Insulin Secretion in Man*
BRATUSCH-MARRAIN, P. R., SMITH, D., & DEFRONZO, R. A. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-973 · Cited by 321
Meier, J. J., Nauck, M. A., Pott, A., Heinze, K., Goetze, O., Bulut, K., Schmidt, W. E., Gallwitz, B., & Holst, J. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.004 · Cited by 266
Metabolic and hormonal effects of muscular exercise in juvenile type diabetics
Berger, M., Berchtold, P., C�ppers, H. J., Drost, H., Kley, H. K., M�ller, W. A., Wiegelmann, W., Zimmermann-Telschow, H., Gries, F. A., Kr�skemper, H. L., et al. (1977) · Diabetologia · doi:10.1007/bf01223279 · Cited by 247
Glucagon Receptor Signaling and Glucagon Resistance
Janah, L., Kjeldsen, S., Galsgaard, K. D., Winther-Sørensen, M., Stojanovska, E., Pedersen, J., Knop, F. K., Holst, J. J., & Wewer Albrechtsen, N. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133314 · Cited by 203
Glucagon Receptor Signaling and Lipid Metabolism
Galsgaard, K. D., Pedersen, J., Knop, F. K., Holst, J. J., & Wewer Albrechtsen, N. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00413 · Cited by 218
Role of glucagon in the pathogenesis of diabetes: The status of the controversy
Unger, R. H. (1978) · Metabolism · doi:10.1016/0026-0495(78)90291-3 · Cited by 216
Diabetic Ketoacidosis: Risk Factors and Management Strategies
Umpierrez, G. E., & Kitabchi, A. E. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302020-00003 · Cited by 204
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome
Umpierrez, G. E., Murphy, M. B., & Kitabchi, A. E. (2002) · Diabetes Spectrum · doi:10.2337/diaspect.15.1.28 · Cited by 197
Importance of Raised Growth Hormone Levels in Mediating the Metabolic Derangements of Diabetes
Press, M., Tamborlane, W. V., & Sherwin, R. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403293101302 · Cited by 198
The role of the growth hormone–insulin‐like growth factor axis in glucose homeostasis
Holt, R. I. G., Simpson, H. L., & Sönksen, P. H. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00827.x · Cited by 191
Hussain, M. A., Schmitz, O., Mengel, A., Keller, A., Christiansen, J. S., Zapf, J., & Froesch, E. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116828 · Cited by 170
Taylor, R., & Agius, L. (1988) · Biochemical Journal · doi:10.1042/bj2500625 · Cited by 164
Liljenquist, J. E., Mueller, G. L., Cherrington, A. D., Keller, U., Chiasson, J.-L., Perry, J. M., Lacy, W. W., & Rabinowitz, D. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108649 · Cited by 168
Important Hormones Regulating Lipid Metabolism
Zhang, D., Wei, Y., Huang, Q., Chen, Y., Zeng, K., Yang, W., Chen, J., & Chen, J. (2022) · Molecules · doi:10.3390/molecules27207052 · Cited by 174
Press, M. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040406 · Cited by 142
Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis
Umpierrez, G. E., DiGirolamo, M., Tuvlin, J. A., Isaacs, S. D., Bhoola, S. M., & Kokko, J. P. (2000) · Journal of Critical Care · doi:10.1053/jcrc.2000.7900 · Cited by 127
Wahren, J., Efendić, S., Luft, R., Hagenfeldt, L., Björkman, O., & Felig, P. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108641 · Cited by 128
Comparison of Hepatic Extraction of Insulin and Glucagon in Conscious and Anesthetized Dogs*
ISHIDA, T., LEWIS, R. M., HARTLEY, C. J., ENTMAN, M. L., & FIELD, J. B. (1983) · Endocrinology · doi:10.1210/endo-112-3-1098 · Cited by 121
Perry, R. J., & Shulman, G. I. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.008387 · Cited by 147
“which likely could not be attributable to hyperglucagonemia, as numerous human (68-73) and rodent studies (57,74) have argued against”
BackgroundEffects of glucagon on plasma amino acids.
Boden, G., Rezvani, I., & Owen, O. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111272 · Cited by 120
Miles, J. M., Haymond, M. W., Nissen, S. L., & Gerich, J. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110911 · Cited by 116
Self-citationDifferential effects of epinephrine on glucose production and disposal in man.
Rizza, R., Haymond, M., Cryer, P., & Gerich, J. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.4.e356 · Cited by 115
Self-citationRates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects.
Baron, A. D., Kolterman, O. G., Bell, J., Mandarino, L. J., & Olefsky, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112169 · Cited by 113
Central mechanisms of glucose sensing and counterregulation in defense of hypoglycemia
Stanley, S., Moheet, A., & Seaquist, E. R. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00226 · Cited by 112
The metabolic role of growth hormone in humans with particular reference to fasting
Nørrelund, H. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.02.005 · Cited by 119
Ketoacidosis in Pancreatectomized Man
Barnes, A. J., Bloom, S. R., Alberti, K. G. M. M., Smythe, P., Alford, F. P., & Chisholm, D. J. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706022962202 · Cited by 109
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Nonketotic Syndrome
Umpierrez, G. E., Khajavi, M., & Kitabchi, A. E. (1996) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)41700-8 · Cited by 120
Reiter, E. O. (2007) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50025-x · Cited by 103
Burge, M. R. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1192 · Cited by 96
Glucagon's Metabolic Action in Health and Disease
Zeigerer, A., Sekar, R., Kleinert, M., Nason, S., Habegger, K. M., & Müller, T. D. (2021) · Comprehensive Physiology · doi:10.1002/cphy.c200013 · Cited by 59
“…this, there has been no solid evidence of Gcgr expression in human adipocytes (417) and glucagon induced lipolysis was only obtained at supra-physiological concentration in human adipocytes (possibly through glucagon stimulated catecholamine secretion) rather than at physiological levels (124).”
Krebs, M., Krssak, M., Nowotny, P., Weghuber, D., Gruber, S., Mlynarik, V., Bischof, M., Stingl, H., Fürnsinn, C., Waldhäusl, W., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7488 · Cited by 78
Cooke, D. W., DiVall, S. A., & Radovick, S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00024-9 · Cited by 90
Xylitol, an Energy Source for Intravenous Nutrition after Trauma
Georgieff, M., Moldawer, L. L., Bistrian, B. R., & Blackburn, G. L. (1985) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607185009002199 · Cited by 84
8 Diabetic coma: A reappraisal after five years
Alberti, K. G. M. M., & Hockaday, T. D. R. (1977) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(77)80046-7 · Cited by 84
Disorders of growth hormone/insulin-like growth factor secretion and action
Backeljauw, P. F., Dattani, M., Cohen, P., & Rosenfeld, R. G. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00019-6 · Cited by 87
Sepsis-induced increases in glucose uptake by macrophage-rich tissues persist during hypoglycemia
Lang, C. H., & Dobrescu, C. (1991) · Metabolism · doi:10.1016/0026-0495(91)90048-2 · Cited by 84
Effects of Short-time Somatostatin Infusion on the Gastric and Intestinal Propulsion in Humans
Johansson, C., Efendić, S., Wisén, O., Uvnäs‐Wallensten, K., & Luft, R. (1978) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527809181925 · Cited by 78
Gravholt, C. H., Møller, N., Jensen, M. D., Christiansen, J. S., & Schmitz, O. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7460 · Cited by 66
Insulin-counteracting hormones: Their impact on glucose metabolism
Bratusch-Marrain, P. R. (1983) · Diabetologia · doi:10.1007/bf00297384 · Cited by 82
Xiao, C., Dash, S., Morgantini, C., Patterson, B. W., & Lewis, G. F. (2014) · Diabetes · doi:10.2337/db13-1654 · Cited by 72
“The effects of somatostatin on carbohydrate and lipid metabolism are mainly through its modulation of the secretion of insulin, glucagon, and growth hormone (35), which were simultaneously replaced in the current study.”
BackgroundEffects of aging on glucose-mediated glucose disposal and glucose transport.
Fink, R. I., Wallace, P., & Olefsky, J. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112533 · Cited by 71
Somatostatin: Physiology and Clinical Applications
Gerich, J. E., & Patton, G. S. (1978) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31813-2 · Cited by 71
Self-citationGut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
Relationship between fatty acids and the endocrine and neuroendocrine system
Bhathena, S. J. (2006) · Nutritional Neuroscience · doi:10.1080/10284150600627128 · Cited by 64
“Glucagon, catecholamines, cortisol and growth hormone, which are counter regulatory hormones to insulin, have predominantly lipolytic activity (Gerich et al. 1976).”
BackgroundEffects of Glucagon on Free Fatty Acid Metabolism in Humans*
JENSEN, M. D., HEILING, V. J., & MILES, J. M. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-308 · Cited by 67
Gerich, J. E., Schultz, T. A., Lewis, S. B., & Karam, J. H. (1977) · Diabetologia · doi:10.1007/bf01234510 · Cited by 66
“Since factors other than insulin lack, such as glucagon [8, 9 ] and growth hormone excess [9, 11], may also contribute to the severity of diabetic hyperglycaemia, the removal or reduction of such insulin antagonists might improve metabolic control in diabetes.”
InfluentialSelf-citationMérida, E., Delgado, E., Molina, L. M., Villanueva-Peñacarrillo, M. L., & Valverde, I. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263154 · Cited by 62
Glucagon and diabetes: A reappraisal
Lefèbvre, P. J., & LUYCKX, A. S. (1979) · Diabetologia · doi:10.1007/bf01223153 · Cited by 77
Hormonal Interactions in the Regulation of Blood Glucose
Felig, P., Sherwin, R. S., Soman, V., Wahren, J., Hendler, R., Saccà, L., Eigler, N., GOLDBERG, D., & Walesky, M. (1979) · Elsevier eBooks · doi:10.1016/b978-0-12-571135-7.50016-3 · Cited by 70
Hormonal Control of Gluconeogenesis
Exton, J. H. (1979) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-0734-2_7 · Cited by 71
Morsci, N. S., Schnabel, R. D., & Taylor, J. F. (2006) · Animal Genetics · doi:10.1111/j.1365-2052.2006.01528.x · Cited by 62
“Growth hormone increases lipolysis (Gerich et al. 1976), stimulates hormone-sensitive lipase and decreases both glucose uptake and lipogenesis (Larsen et al. 2003) in adipose tissues throughout the body.”
BackgroundMetabolic effects of acute and prolonged growth hormone excess in normal and insulin-deficient man
Metcalfe, P., Johnston, D. G., Nosadini, R., �rksov, H., & Alberti, K. G. M. M. (1981) · Diabetologia · doi:10.1007/bf00262014 · Cited by 62
“More recently the lipolytic and ketogenic effects of growth hormone have been demonstra ted in severely insulin-deficient diabetics [11], but few data are available in normal man.”
BackgroundResultInfluentialFleckman, A. M. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30161-0 · Cited by 68
The impact of keto-adaptation on exercise performance and the role of metabolic-regulating cytokines
Sherrier, M., & Li, H. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz145 · Cited by 56
“lipolysis, and induce ketogenesis (59).”
Keller, U., Schnell, H., Girard, J., & Stauffacher, W. (1984) · Diabetologia · doi:10.1007/bf00281115 · Cited by 55
“This dissociation between plasma NEFA levels and ketogenesis agrees with previous findings of increased ketone body concentrations without concomitant changes in plasma NEFA levels during growth hormone administration in normal [12] and in diabetic [14] subjects.”
BackgroundUnger, R. H., & Orci, L. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630160050012 · Cited by 65
Jayasena, C. N., Comninos, A. N., Clarke, H., Donaldson, M., Meeran, K. M., & Dhillo, W. S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04019.x · Cited by 54
Piatti, P., Monti, L. D., Pacchioni, M., Pontiroli, A. E., & Pozza, G. (1991) · Metabolism · doi:10.1016/0026-0495(91)90068-8 · Cited by 54
3Glucose and ketone body kinetics in diabetic ketoacidosis
Miles, J. M., & Gerich, J. E. (1983) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(83)80043-7 · Cited by 53
Self-citationGrowth Factors and Diabetic Complications
Flyvbjerg, A. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01413.x · Cited by 52
Role of Growth Hormone in Diabetes Mellitus
Gerich, J. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403293101310 · Cited by 52
Self-citationThe Role of Glucagon in the Endogenous Hyperglycemia of Diabetes Mellitus
Unger, R. H. (1977) · Annual Review of Medicine · doi:10.1146/annurev.me.28.020177.001003 · Cited by 46
Lewis, S., Wallin, J., Kane, J., & Gerich, J. (1977) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/30.2.160 · Cited by 47
“On the other hand, glucagon response has been shown to stimulate directly hepatic ketogenesis in vitro (27, 28) and recent evidence indicates that it may play an important role in vivo in ketogenesis (29, 30 ).”
BackgroundSelf-citationMcCombe, M. F., Lightman, S., Eckland, D. J. A., HAMILTON, A. M., & Lightman, S. L. (1991) · Eye · doi:10.1038/eye.1991.99 · Cited by 47
Glucagon Immunoreactivities and Amino Acid Profile in Plasma of Duodenopancreatectomized Patients
Müller, W. A., Berger, M., Suter, P. M., Cüppers, H. J., Reiter, J., Wyss, T., Berchtold, P., Schmidt, F. H., Assal, J. P., & Renold, A. E. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109381 · Cited by 47
Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte
Habegger, K. M. (2022) · Diabetes · doi:10.2337/dbi22-0002 · Cited by 46
CRYER, P. E., WHITE, N. H., & SANTIAGO, J. V. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-2-131 · Cited by 43
Insights into incretin-based therapies for treatment of diabetic dyslipidemia
Stemmer, K., Finan, B., DiMarchi, R. D., Tschöp, M. H., & Müller, T. D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.008 · Cited by 43
Malignant Somatostatinoma: Clinical Features and Metabolic Studies*
Axelrod, L., Bush, M. A., Hirsch, H. J., & Loo, S. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-5-886 · Cited by 41
Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Umpierrez, G. E. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_21 · Cited by 43
Metabolic Effects of Somatostatin in Maturity-Onset Diabetes
Tamborlane, W. V., Sherwin, R. S., Hendler, R., & Felig, P. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707282970403 · Cited by 39
Ginsberg, H. N. (1977) · Metabolism · doi:10.1016/0026-0495(77)90041-5 · Cited by 38
Muroyama, K., Murosaki, S., YAMAMOTOI, Y., Odaka, H., CHUNG, H. C., & Miyoshi, M. (2003) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.49.56 · Cited by 41
Ikeda, T., Yoshida, T., Ito, Y., Murakami, I., Mokuda, O., Tominaga, M., & Mashiba, H. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90552-2 · Cited by 36
GOODMAN, H. M. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-629055-4.50008-8 · Cited by 41
Hormonal control of ketone body metabolism in the normal and diabetic state.
Johnston, D. G., & Alberti, K. G. M. M. (1982) · PubMed · Cited by 37
IMPORTANCE OF PITUITARY HORMONES IN ÆTIOLOGY OF DIABETIC KETOACIDOSIS
Barnes, A., KOHNER, E. M., Bloom, S. R., Johnston, D. G., Alberti, K. G. M. M., & Smythe, P. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90965-0 · Cited by 35
Zhang, J., Zheng, Y., Martens, L., & Pfeiffer, A. F. H. (2023) · Nutrients · doi:10.3390/nu15183913 · Cited by 40
“Remarkably, the blockade of GCGRs does not impair the counter-regulation against hypoglycemia [7,40,41].”
Background4Diabetic ketoacidosis — pathogenesis, prevention and therapy
Schade, D. S., & Eaton, R. P. (1983) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(83)80044-9 · Cited by 34
Gluconeogenesis and hypoglycemia
Frizzell, R. T., Campbell, P. J., & Cherrington, A. D. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040107 · Cited by 35
Effect of glucose on plasma glucagon and free fatty acids during prolonged exercise
LUYCKX, A. S., Pirnay, F., & Lefèbvre, P. J. (1978) · European Journal of Applied Physiology · doi:10.1007/bf00429679 · Cited by 36
“, 1976; Unger, 1976), such a role does exist (Gerich et al., 1976) and is reinforced by decreased insulin plasma levels as is the case during prolonged muscular exercise.”
Backgroundα- and β-Cell Responses to Small Changes in Plasma Glucose in the Conscious Dog
Flattem, N. L., Igawa, K., Shiota, M., Emshwiller, M., Neal, D. W., & Cherrington, A. D. (2001) · Diabetes · doi:10.2337/diabetes.50.2.367 · Cited by 31
Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Umpierrez, G. E. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_21-1 · Cited by 32
The acute metabolic effects of glucagon and its interactions with insulin in forearm tissue
Schneider, S. H., Fineberg, S. E., & Blackburn, G. L. (1981) · Diabetologia · doi:10.1007/bf00257430 · Cited by 28
GENUTH, S. M., & Hoppel, C. L. (1981) · Metabolism · doi:10.1016/0026-0495(81)90121-9 · Cited by 28
Normal and Aberrant Growth in Children
Cooke, D. W., DiVall, S. A., & Radovick, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00024-1 · Cited by 31
Beaufr�re, B., Beylot, M., Metz, C. N., Ruitton, A., Fran�ois, R., Riou, J. P., & Mornex, R. (1988) · Diabetologia · doi:10.1007/bf00264768 · Cited by 30
Fat Metabolism in Injury and Stress
Wiener, M., Rothkopf, M. M., Rothkopf, G., & ASKANAZI, J. (1987) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30560-8 · Cited by 27
Pal, B. R., Phillips, P. E., Matthews, D. R., & Dunger, D. B. (1992) · Diabetologia · doi:10.1007/bf00400482 · Cited by 27
“If sufficient insulin is available, much of the ketogenic activity of GH is suppressed [ 28 ].”
BackgroundInfluentialEffect of somatostatin-induced insulinopenia on glucose oxidation in man
Felber, J. P., Thi�baud, D., Maeder, E., J�quier, E., Hendler, R., & DeFronzo, R. A. (1983) · Diabetologia · doi:10.1007/bf00253195 · Cited by 28
3 Hormonal control of ketone body metabolism in the normal and diabetic state
Johnston, D. G., & Alberti, K. G. M. M. (1982) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(82)80019-4 · Cited by 27
Decreased hepatic glucagon responses in Type 1 (insulin-dependent) diabetes mellitus
�rskov, L., Alberti, K. G. M. M., Mengel, A., M⊘ller, N., Pedersen, O. B., Rasmussen, O., Seefeldt, T., & Schmitz, O. (1991) · Diabetologia · doi:10.1007/bf00403290 · Cited by 32
“A direct lipolytic effect of glucagon has previously been described, but not in the presence of basal serum insulin levels [39, 40].”
BackgroundEffects of Free Fatty Acids, Insulin, Glucagon and Adrenaline on Ketone Body Production in Humans
Miles, J. M., Haymond, M. W., & Gerich, J. E. (1982) · Novartis Foundation symposium · doi:10.1002/9780470720691.ch11 · Cited by 24
Self-citationTotal Pancreatectomy Increases the Metabolic Response to Glucagon in Humans*
Bajorunas, D. R., Fortner, J. G., Jaspan, J. B., & Sherwin, R. S. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-439 · Cited by 24
Sonnenberg, G. E., Stauffacher, W., & Keller, U. B. (1982) · Diabetologia · doi:10.1007/bf01271167 · Cited by 24
“in ketone body concentrations was observed after glucagon administration to insulin-withdrawn diabetic patients [3-5].”
BackgroundImpact of Increased Growth Hormone Secretion on Carbohydrate Metabolism in Adolescents with Diabetes
Dunger, D. B., Edge, J. A., PAL, R., Taylor, A. M., Holly, J. M. P., & Matthews, D. R. (1991) · Acta Paediatrica · doi:10.1111/apa.1991.80.s377.69 · Cited by 29
Raskin, P., & Unger, R. H. (1978) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31767-9 · Cited by 24
Metadata
- Authors
- Gerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V, Karam, J. H., & Forsham, P. H.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1976-04-01
- Volume
- 57
- Issue
- 4
- Pages
- 875-884
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC436731
- OpenAlex
- W2003781513
- Cited by
- 198
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 2 · 2015: 2 · 2014: 2 · 2012: 1
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- glucagon, growth hormone, insulin, somatostatin, carbohydrate metabolism, lipid metabolism, lipolysis, ketogenesis, hyperketonemia, hyperglycemia, insulin deficiency, type 1 diabetes, beta-hydroxybutyrate, free fatty acids, glycerol, alanine, insulin antagonism
- MeSH terms
- Adult, Alanine, Blood Glucose, Depression, Chemical, Diabetes Mellitus, Fatty Acids, Nonesterified, Female, Glucagon, Glycerol, Humans, Hydroxybutyrates, Male, Somatostatin, Growth Hormone, Diabetic Ketoacidosis, Carbohydrate Metabolism, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.